Luciferase Vsv Pseudotype
Lab Reagents
Human IgG antibody Laboratories manufactures the luciferase vsv pseudotype reagents distributed by Genprice. The Luciferase Vsv Pseudotype reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact luciferase assay. Other Luciferase products are available in stock. Specificity: Luciferase Category: Vsv Group: Pseudotype
VSV-g Tag Antibody |
|||
abx034631-400ul | Abbexa | 400 ul | EUR 627.6 |
VSV-g Tag Antibody |
|||
abx034631-80l | Abbexa | 80 µl | EUR 343.2 |
VSV- G tag Antibody |
|||
ABD2966 | Lifescience Market | 100 ug | EUR 525.6 |
VSV-G-Tag Antibody |
|||
20-abx242881 | Abbexa |
|
|
VSV-G Tag Antibody |
|||
RQ4681 | NSJ Bioreagents | 100ul | EUR 419 |
VSV-G Tag Antibody (Biotin) |
|||
abx411894-50ug | Abbexa | 50 ug | EUR 526.8 |
VSV-G-tag Conjugated Antibody |
|||
C48120 | SAB | 100ul | EUR 476.4 |
VSV-G-Tag Monoclonal Antibody |
|||
EM1005-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Mouse Monoclonal antibody against VSV-G-Tag. This antibody is tested and validated for WB, ELISA |
VSV-G-Tag Monoclonal Antibody |
|||
EM1005-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Mouse Monoclonal antibody against VSV-G-Tag. This antibody is tested and validated for WB, ELISA |
pCMV-VSV-G Retroviral Vector |
|||
RV-110 | Cell Biolabs | 10 ?g | EUR 860.4 |
Description: Use this vector along with a packaging cell line and a cloning / expression vector for retroviral production. |
Anti-VSV-G-Tag antibody |
|||
STJ96908 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Mouse monoclonal to VSV-G-Tag. |
Anti-VSV-G tag antibody |
|||
STJ140131 | St John's Laboratory | 150 µg | EUR 489.6 |
Description: Goat polyclonal antibody to VSV-G epitope tag. VSV-G epitope tag is useful for the labelling and detection of proteins by immunoprecipitation, immunostaining and immunoblotting techniques. Because of its small size, it is unlikely to affect the tagged protein's biochemical properties. |
Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) |
|||
78637-1 | BPS Bioscience | 100 µl | EUR 795 |
Description: The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike corresponding to the initial strain (Genbank Accession #QHD43416.1) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene; therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 in a Biosafety Level 2 facility.The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) has been validated for use with target cells Vero-E6, Calu-3, and ACE2-HEK293 (BPS Bioscience #79951). Spike VSV Delta G are preferred for use in cells such as Vero-E6 and Calu-3.The infectivity of VSV-Delta G pseudotypes is restricted to a single round of replication, therefore the pseudotypes can be handled using BSL-2 containment practices. |
Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) |
|||
78637-2 | BPS Bioscience | 500 µl x 2 | EUR 3995 |
Description: The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike corresponding to the initial strain (Genbank Accession #QHD43416.1) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene; therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 in a Biosafety Level 2 facility.The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) has been validated for use with target cells Vero-E6, Calu-3, and ACE2-HEK293 (BPS Bioscience #79951). Spike VSV Delta G are preferred for use in cells such as Vero-E6 and Calu-3.The infectivity of VSV-Delta G pseudotypes is restricted to a single round of replication, therefore the pseudotypes can be handled using BSL-2 containment practices. |
Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) |
|||
78642-1 | BPS Bioscience | 100 µl | EUR 795 |
Description: The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1; with D614G mutation) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene; therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 D614G variant in a Biosafety Level 2 facility.The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) has been validated for use with target cells Vero-E6 and ACE2-HEK293 (BPS Bioscience #79951). Spike VSV Delta G is preferred over lentiviral-based spike pseudoviruses for use in cells such as Vero-E6 parental cells. |
Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) |
|||
78642-2 | BPS Bioscience | 500 µl x 2 | EUR 3995 |
Description: The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1; with D614G mutation) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene; therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 D614G variant in a Biosafety Level 2 facility.The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) has been validated for use with target cells Vero-E6 and ACE2-HEK293 (BPS Bioscience #79951). Spike VSV Delta G is preferred over lentiviral-based spike pseudoviruses for use in cells such as Vero-E6 parental cells. |
VSV-G -Tag Mouse Monoclonal Antibody |
|||
T606-100ul | SAB | 100ul | EUR 302.4 |